Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) are suggested to improve clinical decision-making in ischaemic cardiomyopathy. Here, we present a unique cohort of patients who underwent nuclear medicine studies and cardiac magnetic resonance imaging (MRI) both before and 1 year after coronary artery bypass (CABG) surgery to assess benefit from surgery.
Introduction
It is essential that those coronary artery disease (CAD) patients who will profit from revascularization surgery are correctly identified. The optimal result of revascularization is attained when hibernating, but viable myocardium recovers its function. Although traditional coronary angiography can reveal the level of obstruction of vessels in potential need of bypass, it fails to distinguish between viable, hibernating, and non-viable, scarred myocardium. Additional imaging modalities, such as single-photon emission computer tomography (SPECT) and positron emission tomography (PET) may provide further aid in this respect. However, assessment of myocardial viability-with SPECT, for example-has failed to identify ischaemic heart failure patients with differential survival benefit from coronary artery bypass (CABG) surgery, compared with medical therapy alone. 1 Furthermore, patients with three-vessel disease seem to represent a challenge for these imaging studies. 2 -4 Previous studies have suggested that combining PET with perfusion studies like SPECT provides more useful information on the heart. 5, 6 Mismatch areas with low blood flow, as detected by SPECT imaging with technetium-99m ( 99m Tc)-labelled tetrofosmin, but with high metabolism, as detected by 18 F-fluorodeoxyglucose-PET (FDG-PET), represent viable but hypoperfused myocardial tissue. Areas with a low level of FDG and reduced blood flow are classified as a match and indicate non-viable tissue.
Analysis of these studies has relied mainly on subjective views of nuclear imaging specialists. To improve reliability and efficacy, computer tools now assess tissue viability. In this study, we evaluate the accuracy of three quantitative techniques using FDG-PET and 99m Tc-SPECT with a software tool, the Emory Cardiac Toolbox (ECT), in predicting functional outcome after CABG. As a reference, we used cardiac magnetic resonance imaging (MRI), the gold standard for cardiac function measurements. We also assess changes detected in FDG-PET and 99m Tc-SPECT 1 year postoperatively.
Methods

Study group
This study was a part of our project, conducted by our cooperation group, the Helsinki BMMC Collaboration, studying effects of intramyocardial bone marrow-derived cell injection combined with CABG (ClinicalTrials.gov Identifier: NCT00418418). Initially, we enrolled 104 patients from the outpatient clinic of Helsinki University Central Hospital, all scheduled for CABG due to CAD and having heart failure with New York Heart Association (NYHA) II-IV symptoms and a leftventricular ejection fraction (LVEF) of 15 -45%. 7 All participating patients gave their written informed consent. The Ethics Committee of the Hospital District of Helsinki and Uusimaa, Helsinki, Finland, approved study protocols. Before surgery, all patients underwent a 4-to 12-week pharmacotherapy optimization period. Medication contained at least two heart failure drugs at the highest tolerated dose: an angiotensin-converting enzyme inhibitor, or angiotensin II-receptor blocker, or a beta-blocker or a combination, together with diuretics or an aldosterone antagonist. For CAD, medication was a statin and anticoagulation (aspirin or clopidogrel).
If, after pharmacotherapy standardization, the patient still was eligible, with LVEF 15 -45% in the screening echo, he or she was included and randomized to treatment. Eventually, 39 patients remained eligible. Tc-SPECT were performed 1 week before and 1 year after surgery. Clinical evaluation took place preoperatively and 1 year postoperatively.
Cardiac MRI
Cardiac MRI was performed 2 weeks after the screening echo. We used a 1.5-T Siemens Sonata scanner and phase array cardiac coil (Siemens AG, Erlangen, Germany) with electrocardiogram (ECG) gating and breath-holding. For morphological study and further orientation, we used transaxial haste sequences covering the entire heart. LV structure and function were imaged according to a recommended standardized protocol. 8 To line up short-axis images, truefisp cine series were obtained at the vertical and horizontal long axis. Short-axis images were obtained as a stack from the mitral valve plane through the apex. Slice thickness was 8 mm with a 2-mm gap. Temporal resolution was 28 -40 ms. For LV volumetry, short-axis cine images were analysed with Qmass software (Medis Medical Imaging Systems, Leiden, the Netherlands). Endocardial and epicardial contours were planimetered, yielding LV enddiastolic volume (EDV), end-systolic volume, and LVEF. The papillary muscles were included in the ventricular blood pool. As recommended by American Heart Association (AHA) guidelines, 9 LV was divided into 17 segments, of which the most apical one was excluded as it is known to often yield data with motion artefacts. For each segment, wall thickening (WT) was assessed with Argus software (Siemens AG). To obtain an average value for each coronary territory, we calculated a mean from segments belonging to the same territory according to AHA guidelines. One investigator analysed all MRI imaging data in random order. Tc-SPECT perfusion images normalized with the program supplier's normal perfusion database. One method was performed with FDG data only. Before any further analyses, special attention was paid to evaluate the accuracy of basal defects detected by the program as, according to the user's manual, these areas are more challenging for the program.
In the PET-only method, we calculated the size of the non-viable and viable LV myocardium using a threshold of ,50% for non-viable and .50% for viable tissue. This percentage was calculated from the maximal FDG uptake of LV myocardium, and the threshold was adjusted by the investigator.
The second and third methods utilized the normalization protocol provided by the ECT program. Hypoperfused areas were identified by comparison to the normal perfusion database. These excluded, the average count value was calculated for the remaining normally perfused areas. This count then served to scale the average count value for normal areas of FDG study to be equal to that of normal areas of the perfusion study. After this, we obtained two overlapping areas representing the normalized perfusion distribution and the normalized metabolism distribution. In the second method (10% threshold method), a threshold of 10% was set to identify an area scaled as hypoperfused, in which FDG uptake value was .10 percentage points of the perfusion value in the same area. This area was considered as a mismatch, that is, viable but hibernating myocardium. In the third method (50% threshold method), a mismatch area was adjusted to be a region which was, as well, scaled as hypoperfused and had an FDG uptake value of .50% of the maximal FDG uptake area. In both of these methods, hypoperfused areas that had an FDG value below the respective threshold was considered as a match, that is, as non-viable myocardium.
In the quantitative analyses, defect areas were calculated for each of the three coronary territories and for the total myocardium.
Statistical analysis
We used two-sided P-values with significance set at P , 0.05. For nonnormally distributed continuous paired variables, we applied Wilcoxon Signed Ranks test, and for correlations of non-normally distributed variables, calculated Spearman's coefficient. For computation, we used PASW Statistics 18 (IBM SPSS Statistics, IBM Inc., Armonk, NY, USA).
Results
Pre-and perioperative study group characteristics are presented in Tables 1 -2. All patients had three-vessel disease and myocardial regions with a perfusion defect implying myocardial scar in preoperative nuclear medicine imaging studies. Only 4 patients had a history of a symptomatic acute myocardial infarction (AMI); 11 patients had suffered silent infarction without symptoms. One patient (number 4 in Table 2 ) had signs of a perioperative myocardial infarction with level of creatine kinase-myocardial band fraction mass (CK-MBm) arising up to .100 mg/L during the first postoperative day. This patient was included in the analyses comparing preoperative nuclear medicine imaging data with preoperative function but not in the analyses comparing preoperative nuclear medicine imaging data with functional change during follow-up.
No cardiac complications were detectable during follow-up. No clinical signs of graft failure were detected. Median NYHA class was I postoperatively. Median LVEF change was 6% [inter-quartile range (IQR): 0 -11] (P ¼ 0.005). Median change in LVEDV was 240 mL (IQR: 279 to 210) (P ¼ 0.01).
The size of preoperative mismatch and match areas evaluated with the 10% threshold method for each coronary territory correlated significantly with preoperative ventricular WT in the respective area evaluated with MRI (mismatch: r ¼ 20.33, P ¼ 0.03; match: r ¼ 20.40, P ¼ 0.007). With the 50% threshold method, only the preoperative match area correlated significantly with preoperative WT in the respective coronary territory (mismatch: r ¼ 20.21, P ¼ 0.16; match: r ¼ 20.45, P ¼ 0.002). With the PET-only method, significant preoperative correlation also appeared between preoperative defect size and WT (r ¼ 20.41, P ¼ 0.005). No statistically significant correlation was detectable for preoperative LVEF or LVEDV and preoperative total myocardial defect size as evaluated by any of these methods (P ≥ 0.05).
When compared with global functional outcome (change in LVEF) and LV remodelling (change in EDV) 1 year after revascularization, no correlation reaching statistical significance appeared for the preoperative mismatch or match area (in 10 or 50% threshold PET-SPECT) or for the area with reduced FDG (PET-only method) ( Table 3) . Neither was any correlation observed between local functional outcome (change in WT) and local preoperative defect size as evaluated by any method ( Table 3) .
In evaluation of individual patient data, nine patients showed clinically significantly improved cardiac function (change in LVEF ≥5%). The remaining five showed less marked improvement, no change, or a slightly deteriorated LVEF; no patients had severe deterioration in LVEF (less than 25%). Characteristics of these two groups are presented in Table 4 . In the group with significant improvement in LVEF, the match areas with both 10 and 50% threshold methods, and defect area with the PET-only method showed smaller preoperative defect size compared with the group with change in LVEF ,5%. No statistically significant differences were detected in the preoperative sizes of mismatch areas between the groups.
We also evaluated PET-SPECT data obtained 1 year after surgery. According to these imaging studies, during follow-up, cardiac viability among the 14 patients showed deterioration in 7: in these patients, hibernating or scar defect area showed an increase with three or more of the five quantitative variables ( Table 2) . One of these patients was the one with suspected perioperative myocardial infarction (CK-MBm .100 mg/L). When evaluated by MRI, five of these patients showed well-improved LVEF (example patient, number 8, presented in Figure 1) , and all showed reduced LVEDV and low postoperative NYHA class (I-II) When analysing in more detail, these five patients with deterioration in nuclear imaging studies but improvement in LVEF measured by MRI, these patients tended to show preoperatively poorer LVEF (29 vs. 42%) and larger mismatch area ( Table 5) .
Discussion
We set out to investigate the prognostic potential of FDG-PET and 99m Tc-SPECT techniques by analysing CABG patients who had symptomatic moderate heart failure and LV remodelling due to CAD affecting all three coronaries. In the CABG, total revascularization of the myocardium was performed. Despite a good and logical correlation with preoperative function by cardiac MRI (by 10% threshold and PET-only methods) reflecting the capacity of these modalities to detect hypoperfused, hibernating areas, all evaluated PET and PET-SPECT analysis methods for perfusion -metabolism mismatch failed to predict functional outcome assessed with MRI 1 year postoperatively, on both global and coronary territorial level. According to guidelines, heart failure patient selection for surgical revascularization is difficult even with the aid of non-invasive imaging techniques.
11 One meta-analysis showed that, in predicting global functional improvement after revascularization, sensitivity of FDG-PET and 99m Tc-SPECT is quite high, but specificity remains an obstacle: sensitivity and specificity for FDG-PET were 83 and 64%, and for 99m Tc-SPECT, 84 and 68%. 12 To gain repeatability and reproducibility for quantitative analysis of hibernating and scarred areas, we used ECT, commercially available computer software, under the trademark of Emory University (Atlanta, GA, USA Functional outcome after CABG surgery more accuracy for repeat studies. Cardiac MRI is regarded as the gold standard for function measurements. To the best of our knowledge, this study, using measured absolute change in regional WT as a quantitative sign of local benefit and applying this parameter as a reference for comparisons with nuclear medicine imaging data, is the first to take advantage of this approach. When considering the failure of our nuclear imaging techniques to correlate with preoperative global function (LVEF), the importance of measuring also local function is evident: the infarct surrounding myocardium may compensate for the dysfunctional muscle to such an extent that global function remains sufficient, and thus, correlation between MRI and PET and SPECT is detectable only on local level. Naturally, the small patient number in our study may also not be sufficient to show statistically significant correlation between preoperative defect size and global function or volume. In addition, if the total defect area detected by the nuclear imaging method is not specific but contains parts with heterogenic tissue (both hibernating and normal), the correlation analysis may become more hampered on a global level. In a more detailed analysis on territorial level, the confounding heterogenic region may then be located so that it affects only one territory, leaving other territories unaffected, and hence, statistically significant correlation is seen. Global functional outcome after revascularization depends on multiple factors.
14 Hence, producing a multi-factor calculation model has been attempted. Beanlands et al. 15 included as many factors as LV scar score, LV mismatch score, perfusion tracer used, time to surgery, age, diabetes, previous CABG, and tracer/mismatch interaction into their final multivariable model. And yet, this model explained only 36% of the variation in LVEF after CABG, suggesting that many important variables affecting prediction of post-revascularization outcome of global LV function still remain to be discovered.
14 Three-vessel CAD is known to complicate interpretation of imaging data. 4 Balanced hypoperfusion in all coronary territories may lead to misinterpretation of coronary blood flow. Since our patients, however, had a wide range of hypoperfused areas (range 1 -4, median 2), the balanced hypoperfusion should not contribute to our results. On the contrary, one explanation for our results might be technical difficulties related to SPECT. In one group of patients with three-vessel disease in coronary angiography, SPECT underestimated severity of compromised perfusion: it demonstrated no significant perfusion defect or single-vessel disease in 54% of patients. 3 A discrepancy was also detected in another study in patients with multivessel CAD: SPECT tended to underestimate or overestimate significance of coronary stenosis seen at angiography compared with findings in intracoronary pressure-derived fractional flow reserve, the perfusion gold standard. 2 In addition, it has been suggested that 99m Tc-tetrofosmin as a perfusion tracer may overestimate perfusion when coronary flow is low. 16 Ongoing development of perfusion studies using PET techniques, potentially more accurate than SPECT concerning multivessel CAD, 17 and better radiotracer probes suitable for highly sensitive imaging may be able to overcome these problems. 18 Also, using MRI combining delayed enhancement and low-dose dobutamine techniques may prove beneficial as to accuracy in selecting heart failure patients for revascularization. 19 Also confounding viability interpretation may be the fact that both SPECT and PET struggle with detection of subendocardial scar compared with, for example, the capacity of cardiac MRI. 20, 21 Transmural myocardial function has a significant dependence on subendocardial blood flow; 22 possibly subendocardial areas were thus interpreted as viable by SPECT and PET although being irreversibly akinetic in MRI. Moreover, as a unique feature of this study, our patients received standardized and optimized pharmacotherapy before revascularization for 8 weeks. The effect of optimal pharmacotherapy has been neglected in previous trials and may have thus confounded earlier results. 23 In addition, follow-up in our study was quite long, better enabling detection of functional changes in revascularized areas since, after this length of time, hibernation should have subsided and been less likely to confound results.
In the CABG, we aimed at total revascularization of the myocardium. We accomplished anastomoses to all three coronary territories as these patients had an extensive disease with all three coronaries affected. Since our patients' LVEF by MRI improved significantly during their postoperative 1-year follow-up, it is imaginable that we achieved total revascularization and that practically every patient had viable but hypoperfused myocardium that after revascularization gained back its function. Thus, putatively, the mismatch area was eliminated. It is noteworthy that in this sample of 14 patients with both pre-and postoperative imaging data analysed, seven patients showed an actual increase in postoperative defect size although five of them had clear improvement in LVEF, all of them had improvement in LVEDV, and all had low NYHA class (I-II). When we analysed these patients in more detail, it seemed that these patients had higher preoperative mismatch ( Table 5 ). It is logical that patients with high mismatch areas benefit from CABG, showing increased LVEF postoperatively. But as their mismatch areas increased as well during follow-up, it may imply that the tracer applied failed to detect the actually even larger preoperative mismatch area due to poor preoperative myocardial circulation impairing and confounding tracer distribution. When we divided the patients into groups with and without significantly improved LVEF (Table 4 ) to observe any preoperative markers explaining this difference in outcome, the preoperative match area seemed to be, quite logically, smaller in patients with significant improvement. However, in this setting, the impact of preoperative mismatch area failed to show any difference between the groups. Thus, this discrepancy may reflect the insufficient ability of the FDG and/or 99m Tc-labelled tetrofosmin tracers to detect viability and perfusion defects, respectively, in remodelled hearts.
Our study had some limitations. ECT was able to analyse nuclear imaging data only on coronary territorial level. In addition, ECT's normal perfusion database is based on normal values seen in American individuals, which might potentially differ from normal values for Finnish individuals. Including information from stress/rest nuclear imaging studies in the comparisons would also have been interesting, but unfortunately these data were not available for all our patients.
For patient selection, we used echocardiography to measure LVEF since this technique is feasibly available in the clinic. For the actual analyses, however, we measured LVEF with MRI, the gold standard method for functional analyses. Thus, the LVEF yielded by these two imaging methods differed in some patients. In total, three patients (numbers 4, 5, and 6) showed a normal LVEF in preoperative MRI; the same patients had shown low LVEF in preoperative echocardiography. Since echocardiography was decided to be the screening technique and since the patients had a clinical history matching selection criteria, it seemed justified to include them in the study patient cohort; two of these three patients (one suffered a perioperative MI) showed also improvement in LVEF after CABG and also benefit from surgery with improved volumes and alleviated symptoms.
To evaluate graft patency, we could only use information concerning patients' symptoms. To more unequivocally confirm the patency, coronary angiography would have been necessary. The patient numbers were relatively small, which challenge especially the interpretation of the subgroup analyses. But instead of aiming at developing universal guidelines, our goal was to evaluate 14 individual ischaemic heart failure patients with three-vessel disease as single cases and predict their benefits from CABG. In the clinics, considering surgical revascularization for a heart failure patient with ischaemic cardiomyopathy and three-vessel disease means thoroughly evaluating individually each patient because of possible benefits and risks of the operation, especially since these patients represent a group that is truly challenging 11 and heterogenic in the individual extend of remodelling: for our study patients, the inter-quartile ranges for preoperative LVEF were 24-45% and for LVEDV, 162 -282 mL. As according to the current guidelines, the best treatment option for our study patients was CABG, considering the remarkable heterogeneity detected in the results of these PET viability and SPECT perfusion studies, careful attention should be paid when analysing this patient group with three-vessel CAD and remodelled heart and selecting these patients for revascularization procedures. Despite evolving non-invasive cardiac imaging techniques, excluding patients from the potential benefits of revascularization should never solely depend on the results of imaging tests. 24 Aiming at detecting ischaemic but viable areas is important, however, as patients with non-revascularized dysfunctional but viable myocardial areas may face higher mortality. 25 Nevertheless, as also shown here, imaging techniques using FDG-PET for viability and 99m Tc-SPECT for perfusion imaging are able to detect regions with dysfunction and viable tissue reliably. Unfortunately, in our cohort of patients with ischaemic heart failure and three-vessel disease, after coronary surgery these areas show considerable heterogeneity in recovery in these nuclear imaging studies. Future trials should aim at developing new preoperative methods to evaluate this challenging patient group.
